Silver Book Fact

Economics of DR Treatment

Fact image

Laser treatment plus a VEGF inhibitor achieved an incremental cost-effectiveness ratio of $12,410 per quality adjusted life year in patients with DME.

Pershing S, Enns E, Matesic B, Owens D, Goldhaber-Feibert J. Cost-Effectiveness of Treatment of Diabetic Macular Edema. Ann Intern Med. 2014; 160(1): 160-3. http://annals.org/article.aspx?articleid=1811027

Reference

Title
Cost-Effectiveness of Treatment of Diabetic Macular Edema
Publication
Ann Intern Med
Publication Date
2014
Authors
Pershing S, Enns E, Matesic B, Owens D, Goldhaber-Feibert J
Volume & Issue
Volume 160, Issue 1
Pages
160-3
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • For diabetes patients aged 55 and older, medical nutrition therapy was found to reduce the use of hospital services by 9.5% and physicians services by 23.5%.  
  • In a community-based pharmaceutical care services program for 194 participants in 2001, days of sick time decreased at each interval (each year for 1-5 years) for one employer, with estimated…  
  • Intensive Glycemic Control in People with Diabetes
    Intensive glycemic control in diabetics reduced their: Adjusted mean risk of DR by 76% Risk of progression by 54% Rates of laser surgery by 56% Risk of DME by 23%    
  • The initiation of insulin therapy in the management of type 2 diabetes involves an approximate 10% increase in total health care expenditures initially, although this is offset by the consistent…  
  • Blood Pressure Control in Patients with Diabetes
    Tight blood pressure control in type 2 diabetes patients reduced progression of DR by 34% and risk of deterioration by 47% after 9 years.